Home
Archive
Contact
✕
April 2023
Home
2023
April
April 19, 2023
April 19, 2023
Categories
From the Co-Chairs
From the Co-Chairs, April 2023
The ComboMATCH registration trial opens; NCI creates Clinical Trials Innovation unit, unveils revised National Cancer Plan
April 19, 2023
April 19, 2023
Categories
Active Clinical Trials
Now Enrolling: ECOG-ACRIN Opens the ComboMATCH Patient Registration Trial as the Gateway to a Coordinated Set of Treatment Trials
ComboMATCH researchers are discovering new drug combinations that show promise for patients with advanced cancers, based on strong pre-clinical in vivo evidence of therapeutic effectiveness
April 19, 2023
April 19, 2023
Categories
Active Clinical Trials
Trial Spotlight: Kim Reiss on the EA2192/APOLLO Study for Certain Patients with Pancreatic Cancer
This phase 2 study is exploring whether the addition of maintenance PARP inhibition for BRCA- or PALB2-mutated pancreatic cancer improves outcomes
April 19, 2023
April 19, 2023
Categories
Institution Spotlights
Institution Spotlight: Main Line Health and Lankenau Institute for Medical Research
A member of ECOG-ACRIN since 1973
April 19, 2023
April 19, 2023
Categories
Trial Results
Trial Results: ECOG-ACRIN Research Round-Up
Summaries of recently published ECOG-ACRIN research results
April 19, 2023
April 19, 2023
Categories
News in Brief
News in Brief, April 2023
Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more